This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith, J S Articles by Roth, M J Search for Related Content PubMed PubMed Citation Articles by Smith, J S Articles by Roth, M J

 Previous Article  |  Next Article 

J Virol. 1993 July; 67(7): 4037-4049

Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain.

Department of Biochemistry, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway 08854-5635.

ABSTRACT

We have expressed and purified from Escherichia coli a human immunodeficiency virus type 1 (HIV-1) RNase H domain consisting of amino acids 400 to 560 of reverse transcriptase with either an N- or C-terminal polyhistidine tag. The native protease cleavage site of HIV-1 reverse transcriptase is between amino acids 440 and 441. Purification on Ni(2+)-nitrilotriacetate agarose resulted in a highly active RNase H domain dependent on MnCl2 rather than MgCl2. Activity was unambiguously attributed to the purified proteins by an in situ RNase H gel assay. Residues 400 to 426, which include a stretch of tryptophans, did not contribute to RNase H activity, and the polyhistidine tag was essential for activity. Despite the requirement for a histidine tag, the recombinant RNase H proteins retained characteristics of the wild-type heterodimer, as determined by examining activity in the presence of several known inhibitors of HIV-1 RNase H, including ribonucleoside vanadyl complexes, dAMP, and a monoclonal antibody. Importantly, the isolated RNase H domain produced the same specific cleavage in tRNA(3Lys) removal as HIV-1 heterodimer, leaving the 3'-rA (adenosine 5' phosphate) residue of a model tRNA attached to the adjacent U5 sequence. This HIV-1 RNase H domain sedimented as a monomer in a glycerol gradient.

This article has been cited by other articles:

• Roquebert, B., Marcelin, A.-G. (2008). The involvement of HIV-1 RNAse H in resistance to nucleoside analogues. J Antimicrob Chemother 61: 973-975 [Abstract] [Full Text]  
• Lim, D., Gregorio, G. G., Bingman, C., Martinez-Hackert, E., Hendrickson, W. A., Goff, S. P. (2006). Crystal Structure of the Moloney Murine Leukemia Virus RNase H Domain.. J. Virol. 80: 8379-8389 [Abstract] [Full Text]  
• Zuniga, R., Sengupta, S., Snyder, C., Leon, O., Roth, M. J. (2004). Expression of the C-terminus of HIV-1 reverse transcriptase p66 and p51 subunits as a single polypeptide with RNase H activity. Protein Eng Des Sel 17: 581-587 [Abstract] [Full Text]  
• Wisniewski, M., Chen, Y., Balakrishnan, M., Palaniappan, C., Roques, B. P., Fay, P. J., Bambara, R. A. (2002). Substrate Requirements for Secondary Cleavage by HIV-1 Reverse Transcriptase RNase H. J. Biol. Chem. 277: 28400-28410 [Abstract] [Full Text]  
• Lim, D., Orlova, M., Goff, S. P. (2002). Mutations of the RNase H C Helix of the Moloney Murine Leukemia Virus Reverse Transcriptase Reveal Defects in Polypurine Tract Recognition. J. Virol. 76: 8360-8373 [Abstract] [Full Text]  
• Snyder, C. S., Roth, M. J. (2000). Comparison of Second-Strand Transfer Requirements and RNase H Cleavages Catalyzed by Human Immunodeficiency Virus Type 1 Reverse Transcriptase (RT) and E478Q RT. J. Virol. 74: 9668-9679 [Abstract] [Full Text]  
• Severson, W., Partin, L., Schmaljohn, C. S., Jonsson, C. B. (1999). Characterization of the Hantaan Nucleocapsid Protein-Ribonucleic Acid Interaction. J. Biol. Chem. 274: 33732-33739 [Abstract] [Full Text]  
• Goedken, E. R., Marqusee, S. (1999). Metal binding and activation of the ribonuclease H domain from Moloney murine leukemia virus. Protein Eng Des Sel 12: 975-980 [Abstract] [Full Text]  
• Smith, C. M., Smith, J. S., Roth, M. J. (1999). RNase H Requirements for the Second Strand Transfer Reaction of Human Immunodeficiency Virus Type 1 Reverse Transcription. J. Virol. 73: 6573-6581 [Abstract] [Full Text]  
• Keck, J. L., Goedken, E. R., Marqusee, S. (1998). Activation/Attenuation Model for RNase H. A ONE-METAL MECHANISM WITH SECOND-METAL INHIBITION. J. Biol. Chem. 273: 34128-34133 [Abstract] [Full Text]  
• Smith, C. M., Leon, O., Smith, J. S., Roth, M. J. (1998). Sequence Requirements for Removal of tRNA by an Isolated Human Immunodeficiency Virus Type 1 RNase H Domain. J. Virol. 72: 6805-6812 [Abstract] [Full Text]  
• Zhan, X., Crouch, R. J. (1997). The Isolated RNase H Domain of Murine Leukemia Virus Reverse Transcriptase. RETENTION OF ACTIVITY WITH CONCOMITANT LOSS OF SPECIFICITY. J. Biol. Chem. 272: 22023-22029 [Abstract] [Full Text]  
• Palaniappan, C., Wisniewski, M., Jacques, P. S., Le Grice, S. F.J., Fay, P. J., Bambara, R. A. (1997). Mutations within the Primer Grip Region of HIV-1 Reverse Transcriptase Result in Loss of RNase H Function. J. Biol. Chem. 272: 11157-11164 [Abstract] [Full Text]  
• Andrake, M. D., Skalka, A. M. (1996). Retroviral Integrase, Putting the Pieces Together. J. Biol. Chem. 271: 19633-19636 [Full Text]  
• Keck, J. L., Marqusee, S. (1996). The Putative Substrate Recognition Loop of Escherichia coli Ribonuclease H Is Not Essential for Activity. J. Biol. Chem. 271: 19883-19887 [Abstract] [Full Text]  
• Blain, S. W., Goff, S. P. (1996). Differential Effects of Moloney Murine Leukemia Virus Reverse Transcriptase Mutations on RNase H Activity in Mg[IMAGE] and Mn[IMAGE]. J. Biol. Chem. 271: 1448-1454 [Abstract] [Full Text]  
• Andrake, M. D., Skalka, A. M. (1995). Multimerization Determinants Reside in Both the Catalytic Core and C Terminus of Avian Sarcoma Virus Integrase. J. Biol. Chem. 270: 29299-29306 [Abstract] [Full Text]  
• Schultz, S. J., Zhang, M., Kelleher, C. D., Champoux, J. J. (2000). Analysis of Plus-strand Primer Selection, Removal, and Reutilization by Retroviral Reverse Transcriptases. J. Biol. Chem. 275: 32299-32309 [Abstract] [Full Text]  
• Harris, D., Engelman, A. (2000). Both the Structure and DNA Binding Function of the Barrier-to-Autointegration Factor Contribute to Reconstitution of HIV Type 1 Integration in Vitro. J. Biol. Chem. 275: 39671-39677 [Abstract] [Full Text]